1型与2型心肌梗死患者特征及临床结局比较
基于美国全国再入院数据库,在引入2型心肌梗死特异性ICD-10编码后3个月内,比较1型与2型心肌梗死患者的基线特征及住院和出院后结局。2型心肌梗死患者年龄更大、女性更多、心衰/肾病/房颤患病率更高,冠状动脉造影、PCI和CABG使用率更低,住院死亡和30天心梗再入院风险更低。
要点
- 2型心肌梗死患者年龄更大、女性比例更高,心衰、肾病和房颤患病率更高。
- 2型心肌梗死患者接受冠状动脉造影、PCI和CABG的比例显著低于1型心肌梗死。
- 2型心肌梗死患者住院死亡和30天心梗再入院风险更低,但30天全因或心衰再入院风险无差异。
核心结论
- 2型心肌梗死患者具有独特的心血管表型,且管理方式异质,需要经验证的管理策略。
研究设计与样本
- 使用美国全国再入院数据库,在引入2型心肌梗死特异性ICD-10编码后3个月内对心肌梗死患者进行分类。
- 共纳入216657例1型心肌梗死、37765例2型心肌梗死和1525例同时有1型和2型心肌梗死的患者。
主要发现
- 2型心肌梗死患者年龄更大(71岁 vs. 69岁;p < 0.001),女性更多(47.3% vs. 40%;p < 0.001)。
- 2型心肌梗死患者心衰(27.9% vs. 10.9%;p < 0.001)、肾病(35.7% vs. 25.7%;p < 0.001)和房颤(31% vs. 21%;p < 0.001)患病率更高。
- 2型心肌梗死患者冠状动脉造影(10.9% vs. 57.3%;p < 0.001)、PCI(1.7% vs. 38.5%;p < 0.001)和CABG(0.4% vs. 7.8%;p < 0.001)使用率更低。
- 2型心肌梗死患者住院死亡风险更低(调整OR:0.57 [95%CI:0.54 to 0.60]),30天心梗再入院风险更低(调整OR:0.46 [95%CI:0.35 to 0.59])。
- 30天全因再入院或心衰再入院风险无差异。
临床怎么用
- 临床中应识别2型心肌梗死患者独特表型,避免套用1型心肌梗死的血运重建策略。
- 2型心肌梗死患者住院死亡和30天心梗再入院风险较低,但30天全因和心衰再入院风险与1型无差异,需关注合并症管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 myocardial infarction (MI) patients may have different characteristics and outcomes when compared with type 1 MI. OBJECTIVES: The purpose of this study was to compare patients with type 1 MI to those with type 2 MI in the United States. METHODS: Using the Nationwide Readmissions Database, MI patients were categorized over the 3 months following the introduction of an International Classification of Diseases-10th Revision code specific for type 2 MI. Baseline characteristics and inpatient and post-discharge outcomes among both cohorts were compared. RESULTS: There were 216,657 patients with type 1 MI, 37,765 patients with type 2 MI, and 1,525 patients with both type 1 and 2 MI. Patients with type 2 MI were older (71 years vs. 69 years; p < 0.001), were more likely to be women (47.3% vs. 40%; p < 0.001), and had higher prevalence of heart failure (27.9% vs. 10.9%; p < 0.001), kidney disease (35.7% vs. 25.7%; p < 0.001), and atrial fibrillation (31% vs. 21%; p < 0.001). Rates of coronary angiography (10.9% vs. 57.3%; p < 0.001), percutaneous coronary intervention (1.7% vs. 38.5%; p < 0.001), and coronary artery bypass grafting (0.4% vs. 7.8%; p < 0.001) were lower among type 2 MI patients. Patients with type 2 MI had lower risk of in-hospital mortality (adjusted odds ratio: 0.57 [95% confidence interval: 0.54 to 0.60]) and 30-day MI readmission (adjusted odds ratio: 0.46 [95% confidence interval: 0.35 to 0.59]). There was no difference in risk of 30-day all-cause or heart failure readmission. CONCLUSIONS: Patients with type 2 MI have a unique cardiovascular phenotype when compared with type 1 MI, and are managed in a heterogenous manner. Validated management strategies for type 2 MI are needed.
引用
- McCarthy CP, Kolte D, Kennedy KF, et al. Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction. J Am Coll Cardiol. 2021. PMID: 33602466. doi:10.1016/j.jacc.2020.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。